-
CGI1746, σ1R, and Ferroptosis at MAMs
2026-08-20
The reference study identifies CGI1746 as a ferroptosis inhibitor that acts through the sigma-1 receptor at mitochondria-associated membranes. Its findings connect ER–mitochondria calcium transfer, mitochondrial reactive oxygen species, and PUFA-containing lipid handling to ferroptosis execution, creating a mechanistic framework for studying ferroptosis beyond iron metabolism and lipid synthesis.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Assay Logic
2026-08-20
The Annexin V-Cy5/DAPI Apoptosis Kit turns phosphatidylserine exposure and membrane integrity into a time-resolved cell death map. This article connects that readout to P2RX1–CaMKII–PI3K/Akt biology in Ph+ ALL while emphasizing interpretation, controls, and assay selection.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-08-19
Turn mitochondrial depolarization into a quantitative red-to-green fluorescence ratio for apoptosis research, drug screening, and mitochondrial function analysis. This workflow shows how to apply the JC-1 Mitochondrial Membrane Potential Assay Kit to adherent cells, tissue mitochondria, and purified mitochondrial preparations while using CCCP controls to strengthen interpretation.
-
Filipin III: Reliable Membrane Cholesterol Workflows
2026-08-19
This scenario-based guide explains how Filipin III (SKU B6034) supports cholesterol detection in membranes, membrane cholesterol visualization, and interpretation of variable cell-assay results. It connects practical handling, experimental controls, and current immunometabolic literature without treating filipin staining as a substitute for viability or oxysterol-specific assays.
-
Protease Inhibitor Cocktail for LD Assays
2026-08-18
Learn how a Protease Inhibitor Cocktail can preserve labile DFCP1–ATGL complexes during lipid-droplet workflows. This guide connects inhibitor chemistry, EDTA compatibility, and assay design to more defensible mechanistic conclusions.
-
Bestatin (Ubenimex) Workflows for Cancer Research
2026-08-18
Bestatin (Ubenimex) supports targeted aminopeptidase activity measurement, multidrug resistance studies, and mechanistic cancer research. Its unexpected, matrix-dependent stimulation of endothelial invasion makes assay context, dose selection, and orthogonal controls essential.
-
How Human Mucus Shapes C. difficile Biology
2026-08-17
The reference study introduces a primary human intestinal epithelial cell model that produces physiologic mucus and enables direct analysis of Clostridioides difficile behavior at the epithelial interface. Its integrated transcriptomic, metabolic, biophysical, and dynamic measurements show that mucus is not merely a barrier: it can support growth, reshape metabolism, and promote biofilm-associated behavior.
-
Polybrene Workflows for Efficient Gene Delivery
2026-08-17
Learn how Polybrene can improve lentiviral, retroviral, and lipid-mediated DNA delivery while preserving cell health and assay interpretability. This practical guide also shows how controlled transduction can support mutant-p53 model development and chemical-induced-proximity assays.
-
Sulfo-NHS-SS-Biotin for Reversible Receptor Biology
2026-08-16
Sulfo-NHS-SS-Biotin enables reversible surface and protein labeling through an amine-reactive NHS ester and cleavable disulfide linker. This article explains how to deploy it as an assay-design tool for studying membrane-receptor proteostasis, using GABAA receptor biology to distinguish surface delivery, abundance, and function.
-
12-O-tetradecanoyl phorbol-13-acetate (TPA) Workflows
2026-08-15
Build more interpretable PKC and ERK/MAPK experiments with 12-O-tetradecanoyl phorbol-13-acetate (TPA), from rapid phosphorylation assays to mechanistic cancer studies. This guide emphasizes timing, solvent controls, orthogonal readouts, and a practical way to use TPA alongside cisplatin-resistance research.
-
BNNC: Hypoxia-Activated Cyclin K Degradation
2026-08-14
The reference study introduces BNNC, a hypoxia-activated photomolecular glue that releases the Cyclin K degrader (R)-CR8 together with the phototherapeutic agent BSS-Et in tumors. Its combined degradation and phototherapy strategy enhanced DNA damage, apoptosis, and tumor growth control while addressing the tumor selectivity concerns of systemic Cyclin K degradation.
-
LGK-974: A Practical PORCN Inhibitor Workflow
2026-08-14
LGK-974 enables precise, upstream suppression of secreted Wnt ligands for cancer, bone, and pathway-mechanism studies. This guide connects dose selection, target-engagement readouts, model choice, and troubleshooting to practical workflows grounded in product specifications and recent in vivo evidence.
-
Fucoidan, Caveolin-1, and MCF-7 Breast Cancer
2026-08-13
A 2026 study identifies caveolin-1 downregulation as a potential component of Fucoidan activity in MCF-7 breast cancer cells. By combining cytotoxicity, membrane integrity, colony-formation, migration, and protein-expression assays, the work connects a marine sulfated polysaccharide with tumor-associated phenotypes while highlighting the need for causal and in vivo validation.
-
Chromogranin A Drives α-Synuclein Strain Formation
2026-08-13
A 2025 Cell Reports study identifies chromogranin A as a dense-core vesicle factor that promotes early α-synuclein aggregation and generates a distinct, protease-resistant fibril strain. The findings connect presynaptic pathology with synaptic dysfunction and suggest that vesicular matrix proteins influence how α-synuclein pathology begins and spreads.
-
Stress, CerS6, and Liver Mitochondrial Injury
2026-08-12
Liu et al. identify CerS6-derived C16:0 ceramide as a mechanistic link between corticosterone-associated stress and mitochondrial injury in hepatocytes. Their combined rat, cell-culture, mitochondrial fractionation, LC–MS/MS, pathway-inhibition, and gene-silencing strategy provides a useful framework for studying stress-related lipid remodeling while emphasizing the need to preserve proteins and phosphorylation signals during sample processing.